Figure 1.
Figure 1. Darinaparsin treatment of Jurkat (TCL) xenograft in SCID mice results in significant tumor reduction (volume) and improved survival.

Darinaparsin treatment of Jurkat (TCL) xenograft in SCID mice results in significant tumor reduction (volume) and improved survival.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal